VNDA
Vanda Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
VNDA Filings
Filing Date
Form Description
Form Type
2026-01-21
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-21 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-09
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-09 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-08
Form 8-K - Current report
Key Events
2026-01-08 · Key Events
Form 8-K - Current report
2025-12-31
Form 8-K - Current report
Key Events
2025-12-31 · Key Events
Form 8-K - Current report
2025-12-04
Form 8-K - Current report
Key Events
2025-12-04 · Key Events
Form 8-K - Current report
2025-11-28
Form 8-K - Current report
Key Events
2025-11-28 · Key Events
Form 8-K - Current report
2025-10-30
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-10-30 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-29
Vanda Pharmaceuticals Inc. (VNDA) Q3 2025 Earnings Call Transcript
Earnings Call
2025-10-29 · Earnings Call
Vanda Pharmaceuticals Inc. (VNDA) Q3 2025 Earnings Call Transcript
2025-10-29
Form 8-K - Current report
Key Events
2025-10-29 · Key Events
Form 8-K - Current report
2025-10-01
Form 8-K - Current report
Key Events
2025-10-01 · Key Events
Form 8-K - Current report
